Hemostasis Articles & Analysis
29 news found
The infrared coagulator with its multiple-sized tips and pinpoint accuracy has proven to be superior (especially in a wet field) in providing excellent hemostasis, allowing minimal blood loss, and in allowing the clearest visual field in pe,forming both hair transplant and scalp reduction surgery. ...
(PRWEB) January 19, 2018 — Entegrion, Inc. today announced that it has achieved CE mark for the Company’s portable coagulation monitoring system (“PCM”) for use in clinical settings for the viscoelastic measurement of patient whole blood coagulation and hemostasis. The CE marking signifies Entegrion’s declaration that the PCM complies with the ...
Factor XI is a promising and differentiated target for the development of safer anticoagulants because of its critical role in pathological versus normal thrombus formation uncoupling hemostasis from thrombosis. Patients with congenital Factor XI genetic deficiency demonstrate a lower risk for venous thromboembolism and ischemic stroke but rarely have spontaneous bleeding.1 The ...
ByBayer AG
Gandras et al. evaluated[i] the ability of Embrace HES to achieve hemostasis in a porcine mesenteric artery hemorrhage model that replicates injury in humans. ...
Little medical innovation occurred during the fifth to 15th centuries where the standard for wound hemostasis was cautery. Bleeding wounds and vessels were commonly burnt with heated oils. ...
The study design will be presented at the International Society of Thrombosis and Hemostasis (ISTH) Congress in London, U.K in July 2022 and is available at https://www.clinicaltrials.gov/ct2/show/NCT04676048. ...
The new MyOptiLab workflow analysis service is part of a broader strategy aimed at working more closely with laboratories. It is an elaborate process designed to optimise organisational excellence. Workflow analysis might be described as an unbiased, real-time observation of business processes in place. It identifies causes of inefficiency and areas for improvement. MyOptiLab carries out ...
” “From vessel injury to failure of obtaining hemostasis with access closure devices, bleeding complications in interventional procedures continue to pose challenges for clinicians,” said Dr. ...
Her expertise focuses on therapeutic areas of cardiovascular disease (thrombosis, hemostasis, atherosclerosis, coagulation, hyperlipidemia), inflammation, autoimmune diseases, and hematologic malignancies. ...
On World Thrombosis Day, October 13, 2021, Emosis is proud to be a "messenger" of the "Eyes open to Thrombosis" information campaign. Eyes open to Thrombosis WTD is an educational campaign to raise awareness and educate the public to the importance of reducing death and disability from thrombosis. It is a global alliance of thousands of local, regional, national and international ...
Michael Gibson and an Executive Committee comprised of world–renowned cardiac surgeons, interventional cardiologists, and thrombosis/hemostasis experts. Trial start-up activities are underway and we expect the study to start in the first quarter of ...
Abram’s CoagCare System is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders, delivering rapid hemostasis information to improve clinical outcomes. The CoagCare System is designed as a point-of-care (POC) meter and single-use diagnostic test card. ...
Abram’s CoagCare System is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders, delivering rapid hemostasis information to improve clinical outcomes. The CoagCare System is designed as a point-of-care (POC) meter and single-use diagnostic test card. ...
TISSIUM’s vascular sealant is designed to address the issue of quickly achieving hemostasis and preventing post-operative bleeding following peripheral vascular surgeries, while also offering biocompatibility and a simple preparation and application process for surgeons. ...
ByTISSIUM
A selective small molecule targeting a key anticoagulant is a promising and novel approach to restore normal hemostasis and provides a far more convenient therapeutic option for hemophilia patients. ...
The patent, “Methods and Compositions for Achieving Hemostasis and Stable Clot Formation”, also covers design features and mechanisms of action for its first product based on the technology. ...
As such, it is important to highlight the FDA approvals of QNext®, a coagulometer developed in-house, and DG-PT (thromboplastin), one of the main reagents to promote hemostasis. With this latter approval, Grifols became the first company in more than 15 years to earn authorization in the U.S. market to sell instruments and reagents for routine hemostasis ...
Made with HDBRAID technology, the LOBO occluder provides a dense pore structure that spans the vessel lumen to rapidly reduce flow and accelerate hemostasis. The multiple-disk design compounds the occlusive effects of the HDBRAID technology, creating a scaffold for efficient treatment. ...
Vascade MVP Indications EU: VASCADE MVP is indicated for percutaneous closure of femoral venous access sites while reducing time to ambulation, total post-procedure time, time to hemostasis, and time-to-discharge eligibility compared to manual compression in patients who have undergone catheter-based procedures utilizing 6-12 Fr inner diameter procedural sheaths, with single- ...
The poster will feature the biopolymer technology’s 5 complementary mechanisms of action that lead to fast hemostasis of heavy bleeds. 4 of the 5 complementary mechanisms are unique and the subject of the company’s latest patent applications. ...